Publication date: Dec 01, 2024
To determine if integrating VDOT into TB therapy demonstrated non-inferiority to direct observation, and if VDOT utilization increased across Florida after the onset of Covid-19. A statewide programmatic review was conducted of all patients in Florida who initiated tuberculosis treatment between January 2018 – December 2018 and January 2020 – December 2021, as documented by the Florida Department of Health. 1361 patients received treatment within the analysis timeframe. Therapy completion was 97. 2% in those utilizing VDOT compared to 92. 3% utilizing only DOT (p=
| Concepts | Keywords |
|---|---|
| Florida | Covid-19 |
| Therapy | Directly observed therapy |
| Tuberculosis | Public health practice |
| Tuberculosis |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | MESH | Covid-19 |
Original Article
(Visited 2 times, 1 visits today)